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Background
Methods
Results
Astronaut Kate Rubins sequenced DNA on the International Space Station (ISS) for the first
time in August 2016 (Figure 1A). A 2D sequencing library containing an equal mixture of
lambda bacteriophage, Escherichia coli, and Mus musculus was prepared on the ground with a
SQK_MAP006 kit and sent to the ISS frozen and loaded into R7.3 flow cells. After a total of 9
on-orbit sequencing runs over 6 months, it was determined that there was no decrease in
sequencing performance on-orbit compared to ground controls (1). A total of ~280,000 and
~130,000 reads generated on-orbit and on the ground, respectively, identified 90% of reads
that were attributed to 30% lambda bacteriophage, 30% Escherichia coli, and 30% M. musculus
(Figure 1B). Extensive bioinformatics analysis determined comparable 2D and 1D read
accuracies between flight and ground runs (Figure 1C), and data collected from the ISS were
able to construct directed assemblies of E.coli and lambda genomes at 100% and M. musculus
mitochondrial genome at 96.7%. These findings validate sequencing as a viable option for
potential on-orbit applications such as environmental microbial monitoring and disease
diagnosis.
Current microbial monitoring of the ISS applies culture-based techniques that provide colony
forming unit (CFU) data for air, water, and surface samples. The identity of the cultured
microorganisms in unknown until sample return and ground-based analysis, a process that can
take up to 60 days. For sequencing to benefit ISS applications, spaceflight-compatible sample
preparation techniques are required. Subsequent to the testing of the MinION on-orbit, a
sample-to-sequence method was developed using miniPCR™ and basic pipetting, which was
only recently proven to be effective in microgravity. The work presented here details the in-
flight sample preparation process and the first application of DNA sequencing on the ISS to
identify unknown ISS-derived microorganisms.
Figure 1. Astronaut Kate 
Rubins sequenced DNA in 
space for the first time on 
August 26, 2016 (A). No 
decrease in sequencing 
performance on-orbit 
compared to ground 
controls was observed 
(Castro-Wallace 2017). 
Flight- and ground-
generated reads both 
identified 30% lambda 
bacteriophage, 30% 
Escherichia coli, and 30% 
Mus musculus (B) as well 
as maintained similar 1D 
and 2D read accuracies (C). 
Figure 2. Astronaut Peggy Whitson selecting a microbial colony from the Environmental
Health Systems surface sample kit slide for colony PCR with miniPCR ™ and preparing
samples for sequencing with the MinION using Eppendorf Research Plus pipettes and the
SQK-RAS201 Rapid 16S sequencing kit on the International Space Station on August 21, 2017.
Astronaut Peggy Whitson prepared sequencing libraries on-orbit using standard laboratory
methods and pipettes following our optimized spaceflight-compatible method. A total of 10 ng
of microbial community standard DNA (Zymo Research, Irvine, CA) or a scraping of cells from a
microbial colony were prepared for sequencing in triplicate using miniPCR™ (miniPCR,
Cambridge, MA) and modified procedures from SQK-RAS201 16S Rapid Sequencing Kit (Oxford
Nanopore Technologies, Oxford, UK). Pipetting was achieved with Eppendorf Research Plus P20
and P200 pipettes with individually-wrapped epT.I.P.S (Eppendorf, Hauppauge, NY). Triplicate
samples were pooled, and 200 µL of the prepared library was loaded into a R9.4 flow cell in the
MinION (ONT) and sequenced using MinKNOW version 1.1.21 for 48 hours. Both miniPCR ™
and the MinION were operated by a Surface Pro 3. Sequencing data were returned to ground,
basecalled with albacore and analyzed using 16S Sequencing Metrichor workflow as well as
undergoing additional analysis by ONT and UCSC.
Environmental microbial samples were collected from the ISS on August 10, 2017, using the
Environmental Health Systems (EHS) surface sample kit’s tryptic soy agar slide. Astronaut
Peggy Whitson selected a single colony, collected cells by scraping part of the colony with a
pipette tip, and transferred the cells to tubes containing the PCR master mix. This process was
repeated three times (Figure 2). EHS microbial samples were returned to Earth on Soyuz 50
on September 5, 2017, and analyzed in the NASA Johnson Space Center’s Microbiology
laboratory by standard operational methods of biochemical analysis using VITEK (BioMerieux,
Durham, NC) and Sanger sequencing with an ABI 3500 genetic analyzer (ThermoFisher
Scientific, Waltham, MA).
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The first on-orbit sample preparation for DNA sequencing confirmed that standard laboratory
methods and pipetting can be used in the microgravity environment of space without risk to
sequencing performance (Figure 3).
Figure 3. Sequencing run metrics from the first on-orbit sample preparation and sequencing of
Zymo microbial community standard DNA using modified SQK-RAS201 Rapid 16S sequencing kit,
miniPCR ™ and the MinION compared to ground control. Read lengths ~1450 bp (A) and q score
~11 (B) were similar between flight and ground control runs. The speed of in-flight sequencing was
slightly faster than the ground control run (C) and flight operations generated more total reads (D).
This increased flight performance may be related to increased available pore count in flight
compared to ground R9.4 flow cells (E). Species level % identification of community were similar
between flight and ground (F).
Figure 4. Species level taxonomic identification of unknown ISS-derived microorganisms collected
and cultured as part of the Environmental Health Systems routine microbial monitoring efforts
sequenced on the ISS using SQK-RAS201 16S Rapid Sequencing Kit, miniPCR ™ and the MinION.
For the first time, microorganisms collected from, and cultured on, the ISS were identified at species
level on-orbit through 16S sequencing. Analysis of the returned samples using biochemical methods
and Sanger sequencing revealed almost identical identifications to those obtained on the ISS (Figure 4
and Table 1).
Colony Detection Method Sample ID %ID
1 Biochemical Staphylococcus epidermidis 96.0
2 Biochemical Staphylococcus hominis hominis 97.0
3 Biochemical Staphylococcus capitis 94.0
1 Sanger Sequencing Staphylococcus hominis hominis (ATCC=27844) 99.9
2 Sanger Sequencing Staphylococcus hominis hominis (ATCC=27844) 100.0
3 Sanger Sequencing Staphylococcus capitis capitis (ATCC=27840) 99.9
Table 1. Ground-based analysis of the returned sample. The 3 bacterial colonies selected
by the crew were identified using biochemical and Sanger sequencing techniques per
normal laboratory procedures.
16S species level ID 
>90% accuracy
% reads 
S. hominis 71.3%
S. capitis 17.0%
Available Pore Count
Flight Ground
Group 1 485 484
Group 2 408 375
Group 3 249 202
Group 4 78 46
Total 1220 1107
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One year and 2 days following the demonstration of successful nanopore sequencing in space, an
end-to-end sample-to-sequence process resulted in the first in-flight identifications of ISS-derived
microorganisms. To date, all sequencing experiments in space have produced data that parallel that of
ground controls. The ability to prepare and sequence DNA in the spaceflight environment will
revolutionize space-based research and in-flight medical operations.
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